Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 1 institution in 1 country.
Toshitaka SawamuraDepartment of Internal Medicine, Asanogawa General Hospital, 83 Kosakamachi, Kanazawa 910-8621, Japan.ORCID 0000-0003-1279-4947
Shigehiro KarashimaDepartment of Health Promotion and Medicine of the Future, Kanazawa University, 13-1 Takaramachi, Kanazawa 920-8641, Japan.ORCID 0000-0002-4084-9653
Azusa OhbatakeDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, 13-1 Takaramachi, Kanazawa 920-8641, Japan.
Takuya HigashitaniDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, 13-1 Takaramachi, Kanazawa 920-8641, Japan.
Ai OhmoriDepartment of Internal Medicine, Asanogawa General Hospital, 83 Kosakamachi, Kanazawa 910-8621, Japan.
Kei SawadaDepartment of Internal Medicine, Asanogawa General Hospital, 83 Kosakamachi, Kanazawa 910-8621, Japan.
Rika YamamotoDepartment of Internal Medicine, Asanogawa General Hospital, 83 Kosakamachi, Kanazawa 910-8621, Japan.
Mitsuhiro KometaniDepartment of Internal Medicine, Asanogawa General Hospital, 83 Kosakamachi, Kanazawa 910-8621, Japan.ORCID 0000-0003-0461-3018
Yuko KatsudaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, 13-1 Takaramachi, Kanazawa 920-8641, Japan.
Takashi YonedaDepartment of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, 13-1 Takaramachi, Kanazawa 920-8641, Japan.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study. · full record | OpenQuestion